Search Results

There are 7870045 results for: content related to: Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication

  1. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  3. You have free access to this content
    Abstracts

    Movement Disorders

    Volume 32, Issue S2, June 2017, Pages: S1–S627,

    Version of Record online : 2 JUN 2017, DOI: 10.1002/mds.27087

  4. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  5. You have free access to this content
    Effects in vitro and in vivo by apomorphine in the rat corpus cavernosum

    British Journal of Pharmacology

    Volume 146, Issue 2, September 2005, Pages: 259–267, Kenshi Matsumoto, Masaki Yoshida, Karl-Erik Andersson and Petter Hedlund

    Version of Record online : 30 JAN 2009, DOI: 10.1038/sj.bjp.0706317

  6. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: Long-term follow-up study of 64 patients

    Movement Disorders

    Volume 17, Issue 6, November/December 2002, Pages: 1235–1241, Alice J. Manson, Kirsten Turner and Andrew J. Lees

    Version of Record online : 23 JUL 2002, DOI: 10.1002/mds.10281

  7. A Retrospective Evaluation of the Frequency of Impulsive Compulsive Behaviors in Parkinson's Disease Patients Treated with Continuous Waking Day Apomorphine Pumps

    Movement Disorders Clinical Practice

    Volume 4, Issue 3, May/June 2017, Pages: 323–328, Pedro Barbosa, Andrew J. Lees, Cathy Magee, Atbin Djamshidian and Thomas T. Warner

    Version of Record online : 11 AUG 2016, DOI: 10.1002/mdc3.12416

  8. Apomorphine-induced modulation of neural activities in the ventrolateral striatum of rats

    Synapse

    Volume 67, Issue 7, July 2013, Pages: 363–373, Satoshi Fujita, Risako Kato, Yilong Cui, Masanori Terakado, Kurando Suga, Noriaki Koshikawa and Masayuki Kobayashi

    Version of Record online : 7 MAR 2013, DOI: 10.1002/syn.21644

  9. Development and evaluation of perfluorocarbon nanobubbles for apomorphine delivery

    Journal of Pharmaceutical Sciences

    Volume 98, Issue 10, October 2009, Pages: 3735–3747, Tsong-Long Hwang, Yin-Ku Lin, Chen-Hsien Chi, Tse-Hung Huang and Jia-You Fang

    Version of Record online : 20 JAN 2009, DOI: 10.1002/jps.21687

  10. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single-dose challenges

    Movement Disorders

    Volume 20, Issue 2, February 2005, Pages: 151–157, Regina Katzenschlager, Andrew Hughes, Andrew Evans, Alice J. Manson, Marion Hoffman, Lesley Swinn, Hilary Watt, Kailash Bhatia, Niall Quinn and Andrew J. Lees

    Version of Record online : 10 SEP 2004, DOI: 10.1002/mds.20276

  11. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  12. Dopaminergic regulation of orexin neurons

    European Journal of Neuroscience

    Volume 21, Issue 11, June 2005, Pages: 2993–3001, Michael Bubser, Jim R. Fadel, Lela L. Jackson, James H. Meador-Woodruff, Deqiang Jing and Ariel Y. Deutch

    Version of Record online : 24 JUN 2005, DOI: 10.1111/j.1460-9568.2005.04121.x

  13. Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo-controlled, randomized, double-blind, cross-over study

    Movement Disorders

    Volume 25, Issue 3, 15 February 2010, Pages: 368–376, Olivier Rascol, Jean-Philippe Azulay, Olivier Blin, Anne-Marie Bonnet, Christine Brefel-Courbon, Pierre Césaro, Philippe Damier, Bérengère Debilly, Frank Durif, Monique Galitzky, Jean-Marie Grouin, Sylvie Pennaforte, Gabriel Villafane, Sadek Yaici and Yves Agid

    Version of Record online : 8 JAN 2010, DOI: 10.1002/mds.22922

  14. Oral apomorphine delivery from solid lipid nanoparticleswith different monostearate emulsifiers: Pharmacokinetic and behavioral evaluations

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 2, February 2011, Pages: 547–557, Ming-Jun Tsai, Yaw-Bin Huang, Pao-Chu Wu, Yaw-Syan Fu, Yao-Ren Kao, Jia-You Fang and Yi-Hung Tsai

    Version of Record online : 25 AUG 2010, DOI: 10.1002/jps.22285

  15. You have free access to this content
    Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction

    BJU International

    Volume 98, Issue 1, July 2006, Pages: 125–131, KARYN M. MACLENNAN, ANDREW BOSHIER, LYNDA V. WILTON and SAAD A.W. SHAKIR

    Version of Record online : 8 JUN 2006, DOI: 10.1111/j.1464-410X.2006.06253.x

  16. Morphological and Biochemical Evidence that Apomorphine Rescues Striatal Dopamine Terminals and Prevents Methamphetamine Toxicity

    Annals of the New York Academy of Sciences

    Volume 965, Issue 1, June 2002, Pages: 254–266, G. BATTAGLIA, M. GESI, P. LENZI, C. L. BUSCETI, P. SOLDANI, F. ORZI, L. RAMPELLO, F. NICOLETTI, S. RUGGIERI and F. FORNAI

    Version of Record online : 24 JAN 2006, DOI: 10.1111/j.1749-6632.2002.tb04167.x

  17. Transdermal apomorphine permeation from microemulsions: A new treatment in Parkinson's disease

    Movement Disorders

    Volume 19, Issue 8, August 2004, Pages: 937–942, Lorenzo Priano, Gianni Albani, Andrea Brioschi, Sara Calderoni, Leonardo Lopiano, Mario Rizzone, Roberta Cavalli, Maria Rosa Gasco, Francesco Scaglione, Franco Fraschini, Bruno Bergamasco and Alessandro Mauro

    Version of Record online : 16 MAR 2004, DOI: 10.1002/mds.20054

  18. You have free access to this content
    The pharmacology and clinical pharmacokinetics of apomorphine SL

    BJU International

    Volume 88, Issue s3, October 2001, Pages: 18–21, A. Argiolas and H. Hedlund

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1464-4096.2001.00124.x

  19. You have full text access to this OnlineOpen article
    Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease

    Movement Disorders Clinical Practice

    Volume 4, Issue 1, January/February 2017, Pages: 78–83, Stuart Isaacson, Mark Lew, William Ondo, Jean Hubble, Thomas Clinch and Fernando Pagan

    Version of Record online : 25 MAY 2016, DOI: 10.1002/mdc3.12350

  20. You have free access to this content
    Effects of Lithium Carbonate on Apomorphine-Induced Sniffing Behaviour in Rats

    Pharmacology & Toxicology

    Volume 91, Issue 3, September 2002, Pages: 135–139, Soheila Fazli-Tabaei, Seyed-Hossein Yahyavi and Mohammad-Reza Zarrindast

    Version of Record online : 30 SEP 2002, DOI: 10.1034/j.1600-0773.2002.910308.x